Eupnoos Ltd

Eupnoos was created to improve respiratory health by providing global access to a low cost, easy to use, personalised screening and monitoring digital solutions for cardio-pulmonary diseases. Our mission is to reduce health inequity and inequality by converting the 6.5 billion smartphone devices in people’s hands into a screening and disease diagnostics systems for exacerbations associated with Chronic Obstructive Pulmonary Diseases (COPD) and associated co-morbidities such as Chronic Heart Failure (CHF) using respiratory sound.

Value our organisation can add in a joint tender​

Eupnoos will provide it’s technology expertise and API enabled platform in the following capacitySoftware only, Smartphone application for screening, diagnostics and monitoring using multi-modal inputs such as audio, text and movementAI enabled case finding and population health surveillance : assessing and predicting the risk of developing cardio-pulmonary diseasesAI enabled case finding and population health surveillanceCare Management Dashboard: Smartphone, sensors and AI to identify risk of exacerbations and/or deterioration, symptoms associated with comorbidities, rehabilitation, self-management and treatment response

Areas of cooperation sought​

We would like to join a consortium targeting the management of respiratory diseases and associated cardio-pulmonary co-morbid conditions

Organisation details

Organisation type:

Medtech/ICT company

Organisation size:

Micro (< 10 employees and ≤ € 2 m turnover)

Headquarters country​:

United Kingdom

Website:

www.eupnoos.com

Contact details

Contact person:

Arshia Gratiot

Job title:

CEO

Email address:

arshia@eupnoos.com